Nov 2024 Ketamine: Considerations in Clinical Practice
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Clinical Update
Aug 2024 Telemedicine Improvements After Epidemics Collide
Telemedicine, or telehealth, utilizes telecommunication technologies through audio or audio/visual, real-time, two-way communication to provide clinical services to patients outside...
Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
May 2024 Gabapentin: Highlights and Challenges
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
